Why we can't rely on science alone to make public health decisions is a question that has sparked widespread debate among policymakers, healthcare professionals, and communities alike. While scientific research…
America’s Fractured Trust in Science: Causes, Trends, and Solutions: Public trust in science is facing unprecedented challenges in today's rapidly changing world. Once regarded as an unwavering pillar of progress…
The Gilead Sciences and U.S. government settlement over HIV drug patents marks a crucial turning point in the fight against HIV. After years of legal battles over the patents for…
The U.S. withdrawal from the World Health Organization (WHO) has sparked intense debate and concern across the globe. As one of the WHO’s largest contributors, the United States’ decision to…
Stanley Druckenmiller has once again made headlines with his cautious outlook on the stock market, despite the growing optimism among corporate leaders. As investors navigate an unpredictable financial landscape, Druckenmiller’s…
Corporate America Shifts Away from DEI and ESG Initiatives Under New Administration; DEI and ESG initiatives have been at the forefront of corporate America for years, shaping how companies approach…
Dow Jones Futures Rise Despite President Trump's Tariff Threats on Canada and Mexico; Dow Jones futures rise despite ongoing trade tensions, signaling investor confidence even as President Donald Trump threatens…